Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-04-21 @ 12:05 PM
Study NCT ID:
NCT06873659
Status:
RECRUITING
Last Update Posted:
2025-09-03
First Post:
2025-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Sponsor:
Qurgen Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SON-DP-A003-ST
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None